Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) has 162 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Nextech Invest, Ltd. | 31 Mar, 2026 | 7,162,637 | 0 | 0.00% | $90,750,611.00 |
| Nextech Invest, Ltd. | 31 Mar, 2026 | 7,162,637 | 0 | 0.00% | $58,590,371.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 6,728,116 | 0 | 0.00% | $55,035,989.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 6,728,116 | 0 | 0.00% | $85,245,230.00 |
| VIKING GLOBAL INVESTORS LP | 31 Mar, 2026 | 6,572,691 | -9 | 0.00% | $53,764,612.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,976,454 | 109,499 | 1.87% | $75,721,672.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,866,955 | 598,433 | 11.36% | $47,991,692.00 |
| VIKING GLOBAL INVESTORS LP | 31 Mar, 2026 | 5,824,533 | -748,158 | -11.38% | $73,796,833.00 |
| VR Adviser, LLC | 31 Mar, 2026 | 5,676,230 | -920,655 | -13.96% | $46,431,561.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 5,387,783 | 5,387,783 | 0.00% | $68,264.00 |
| Pfizer Inc | 31 Mar, 2026 | 5,376,344 | 0 | 0.00% | $43,978,494.00 |
| Pfizer Inc | 31 Mar, 2026 | 4,780,401 | -595,943 | -11.08% | $57,651,636.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 4,541,974 | -108,164 | -2.33% | $37,153,347.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 4,514,929 | 0 | 0.00% | $37,753,841.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 4,514,929 | 0 | 0.00% | $58,476,915.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,504,096 | 0 | 0.00% | $36,843,505.00 |
| ALKEON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,504,096 | 0 | 0.00% | $57,066,896.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 4,319,765 | -1,356,465 | -23.90% | $54,731,423.00 |
| State Street Corp | 31 Mar, 2026 | 4,258,397 | 1,854,458 | 77.14% | $34,833,687.00 |
| NEA Management Company, LLC | 31 Mar, 2026 | 4,118,621 | 0 | 0.00% | $52,182,928.00 |